Sertraline salts and sustained-release dosage forms of sertraline
US6517866B1 · kind B1 · utility
32Cited by
26References
116Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 7, 1999 |
| Grant date | Feb 11, 2003 |
| Priority date | — |
| Expiry date | Sep 7, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/5047
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Sustained release dosage forms of sertraline which release sertraline at a rate between 1 mgA/hr and 40 mgA/hr. The dosage forms may exhibit an initial delay period during which sertraline is released at a rate less than 1 mgA/hr.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.